RA0253

antibody from Oursmab

Targeting: FGFR3 ACH, CD333, CEK2, JTK4

Western blot

ELISA

Immunocytochemistry

Flow cytometry

Functional assay

Antibody data

Submit

Validation data

Product number: RA0253 - Provider product page
Provider: Oursmab
Product name: Vofatamab (Biosimilar Reference Antibody) (FGFR3)
Antibody type: Monoclonal
Description: Vofatamab (B-701) is an investigational fully human monoclonal antibody that specifically targets Fibroblast Growth Factor Receptor 3 (FGFR3). It is being developed primarily for the treatment of advanced urothelial carcinoma (bladder cancer), particularly in tumors with FGFR3 gene alterations, to inhibit tumor growth driven by aberrant FGFR3 signaling.
Reactivity: Human
Isotype: IgG
Vial size: 100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg
Concentration: Bottled at the concentration indicated on the vial.
Storage: Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.

FGFR3 protein structure - RA0253 shown in red.